본문 바로가기
KERD
논문KCI 등재

소아에서 2009 신종 인플루엔자 A (H1N1) 중증 폐렴과 스테로이드 치료

Severe Pneumonia Caused by 2009 Pandemic Influenza A (H1N1) Virus in Children and Corticosteroid Treatment

김종희|마상혁|이경일|강진한|손유락
대한소아감염학회 (The Korean Society of Pediatric Infectious Diseases)|2011.12|Pediatric Infection and Vaccine|제18권 제2호|pp. 193-200

1

조회

0

다운로드

2

인용

0

참고문헌

키워드

ChildrenPneumoniaCorticosteroidH1N1 influenza virus

초록

Purpose:The effect of corticosteroid on severe pneumonia caused by 2009 pandemic influenza (H1N1) A virus is controversial. This study was aimed to present the effects of early, short-term corticosteroid treatment for severe pneumonia with this virus infection. Methods:A retrospective analysis was performed on severe pneumonia patients (37 patients) who had severe respiratory distress at presentation requiring oxygen therapy and received intravenous methylprednisolone (MP, 8-10 mg/kg, divided in 4 doses/day for 2-3 days) with oseltamivir. The clinical and laboratory characteristics of the patients were evaluated through the medical records and chest radiographic findings. Results:The mean age and male-to-female ratio of the patients were 6.5±2.9 years of age, and 3.4:1 (male 29 patients), respectively. The 5-9 aged group was predominant among the age groups (25 patients, 67.6%). Duration of fever prior to admission was 1.4±0.6 days and dyspnea developed within 24 h after beginning of respiratory symptoms in all patients. All patients were previously healthy and received oseltamivir within 48 h. Thirteen patients (35.1%) developed dyspnea during oseltamivir treatment. Following MP infusion, all 37 patients including 13 progressive pneumonia patients during oseltamivir treatment showed an immediate halt in the progression of pneumonic infiltration with rapid clinical improvement. There were no side-effects following steroid use. Conclusion:For severe pneumonia patients, early corticosteroid treatment halted clinical exacerbation, and possibly prevented progression to acute respiratory distress syndrome. Further controlled clinical studies are needed for the role of corticosteroids and antivirals on severely affected patients with influenza virus infections.

Abstract

Purpose:The effect of corticosteroid on severe pneumonia caused by 2009 pandemic influenza (H1N1) A virus is controversial. This study was aimed to present the effects of early, short-term corticosteroid treatment for severe pneumonia with this virus infection. Methods:A retrospective analysis was performed on severe pneumonia patients (37 patients) who had severe respiratory distress at presentation requiring oxygen therapy and received intravenous methylprednisolone (MP, 8-10 mg/kg, divided in 4 doses/day for 2-3 days) with oseltamivir. The clinical and laboratory characteristics of the patients were evaluated through the medical records and chest radiographic findings. Results:The mean age and male-to-female ratio of the patients were 6.5±2.9 years of age, and 3.4:1 (male 29 patients), respectively. The 5-9 aged group was predominant among the age groups (25 patients, 67.6%). Duration of fever prior to admission was 1.4±0.6 days and dyspnea developed within 24 h after beginning of respiratory symptoms in all patients. All patients were previously healthy and received oseltamivir within 48 h. Thirteen patients (35.1%) developed dyspnea during oseltamivir treatment. Following MP infusion, all 37 patients including 13 progressive pneumonia patients during oseltamivir treatment showed an immediate halt in the progression of pneumonic infiltration with rapid clinical improvement. There were no side-effects following steroid use. Conclusion:For severe pneumonia patients, early corticosteroid treatment halted clinical exacerbation, and possibly prevented progression to acute respiratory distress syndrome. Further controlled clinical studies are needed for the role of corticosteroids and antivirals on severely affected patients with influenza virus infections.

참고문헌 (33)

  1. Neumann G, "Emergence and pandemic potential of swine-origin H1N1 influenza virus", Nature, 459, pp.931~939 (2009)
  2. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, "Emergence of a novel swine-origin influenza A (H1N1) virus in humans", N Engl J Med, 360, pp.2605~2615 (2009)
  3. "Global Alert and Response"[URL]
  4. 김우주, "신종인플루엔자 A", H1N1 대유행: 현황과 전망, 2009, pp.52(8), 787~794[DOI]
  5. rean Center for Disease Control, "Epidemiology of early detected Novel Influenza A (H1N1) in Korea, 2009", Public Health Wkly Rep, 2, pp.689~691 (2009)
  6. 이흔지, "2009 신종 인플루엔자 감염으로 입원한 소아 환자들의 임상적 특성", 대한소아알레르기및호흡기학회지, 20(2), pp.130~137 (2010), 대한 소아알레르기 호흡기학회
  7. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza, "Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection", N Engl J Med, 362, pp.1708~1719 (2010)
  8. Falagas ME, "Treatment options for 2009 H1N1 influenza: evaluation of the published evidence", Intern J Antimicrob Agents, 35, pp.421~430 (2010)
  9. Reddy D, "Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir", J Antimicrob Chemother, 65(2), pp.35~40 (2010)
  10. de Jong MD, "Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia", Nat Med, 12, pp.1203~1207 (2006)
  11. Eichelberger MC, "The cotton rat as a model to study influenza pathogenesis and immunity", Viral Immunol, 20, pp.243~249 (2007)
  12. La Gruta NL, "A question of self-reservation: immunopathology in influenza virus infection", Immunol Cell Biology, 85, pp.85~92 (2007)
  13. To KK, "Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection", Clin Infect Dis, 50, pp.850~859 (2010)
  14. Lee KY, "Hyperimmune cells (T cells) may be responsible for acute lung injury in influenza virus infections: a need for early immune-modulators for severe cases", Med Hypotheses, 76, pp.64~69 (2011)
  15. Quispe-Laime AM, "H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment", Intensive Care Med, 36, pp.33~41 (2010)
  16. Linko R, "FINN H1N1-study group. Corticosteroid therapy in intensive care unit patients with PCR-confirmed influenza A (H1N1) infection in Finland", Acta Anesth Scand
  17. Confalonieri M, "Methylprednisolone infusion for life- threatening H1N1-virus infection", Ther Adv Respir Dis, 4, pp.233~237 (2010)
  18. Roberts C, "Steroid-sensitive post-viral inflammatory pneumonitis (PVIP)", Am J Respir Crit Care Med, 182, pp.1089~1090 (2010)
  19. Kil HR, "Early corticosteroid treatment for severe pneumonia caused by 2009 H1N1 influenza virus", Critical Care, 15, pp.413~ (2011)
  20. Annane D, "Pro: The illegitimate crusade against corticosteroids for severe H1N1 pneumonia", Am J Respir Crit Care Med, 183, pp.1125~1126 (2011)
  21. Rhim JW, "Epidemiological and clinical characteristics of childhood pandemic 2009 H1N1 virus infection: An observational cohort study", BMC infect Dis, 11, pp.225~ (2011)
  22. Bettinger JA, "Pandemic influenza in Canadian children: a summary of hospitalized pediatric cases", Vaccine, 28, pp.3180~3184 (2010)
  23. Matthay MA, "Con: Corticosteroids are not indicated for treatment of acute lung injury from H1N1 viral pneumonia", Am J Respir Crit Care Med, 183, pp.1127~1128 (2011)
  24. Kim SH, "Corticosteroid treatment in critically ill patients with pandemic influenza A", H1N1 2009 infection: analytic strategy using propensity scores, 2011, pp.183, 1207~1214
  25. Brun-Buisson C, "Early corticosteroids in severe Influenza A", H1N1 pneumonia and acute respiratory distress syndrome, 2011, pp.183, 1200~1206
  26. Witkop CT, "Novel influenza A (H1N1) outbreak at the US Air Force Academy: epidemiology and viral shedding duration", Am J Prev Med, 38, pp.121~126 (2010)
  27. Confalonieri M, "Corticosteroids do not cause harmful increase of viral load in severe H1N1 virus infection", Intensive Care Med, 36, pp.1780~1781 (2010)
  28. Aviram G, "H1N1 influenza: initial chest radiographic findings in helping predict patient outcome", Radiology, 255, pp.252~259 (2010)
  29. 최승희, "Radiologic Review of an Outbreak of the Pandemic (H1N1) 2009 Virus Infection at a University Hospital in Seoul, Korea", 대한영상의학회지, 64(4), pp.341~350 (2011), 대한영상의학회
  30. Korppi M, "The value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children", Acta Pediatr, 97, pp.943~947 (2008)
  31. "World Health Organization: Human infection with new influenza A (H1N1) virus: Clinical observations from a school associated outbreak in Kobe, Japan, May 2009", Wkly Epidemiol Rec, 84, pp.237~248 (2009)
  32. Jain S, "2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009", N Engl J Med, 361, pp.1935~1944 (2009)
  33. Tang BM, "Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systemic review and meta-analysis", Crit Care Med, 37, pp.1594~1603 (2009)

관련 논문AI추천

빈호흡을 보이는 폐렴이 동반된 신종 인플루엔자 감염 소아의 임상 양상김여향, 이동원, 이희정, 최보금, 현명철대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2010 · 제20권 제2호2009 신종 인플루엔자 감염으로 입원한 소아 환자들의 임상적 특성강은경, 민성주, 이흔지, 최장환대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2010 · 제20권 제2호소아에서 2009 신종 인플루엔자 A (H1N1) 바이러스 감염의 임상적 특징김원덕, 박수현, 손유락대한소아감염학회 · Pediatric Infection and Vaccine2011 · 제18권 제2호2009-2011년 신종 인플루엔자 A (H1N1)와 계절 인플루엔자 감염으로 입원한 소아 환자들의 임상 양상과 경과 비교차한, 김지은, 노정희, 선용한, 손동우, 심소연, 양송이, 은병욱, 조강호대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2012 · 제22권 제3호2009 Influenza A H1N1 감염 중 소아 중증 환자에 대한 고용량 Oseltamivir 투여 효과김자경, 민세라, 안성연, 양정희, 이준호, 이현수, 조현석대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2014 · 제2권 제1호단일 2차 기관에서 소아 마이코플라스마 폐렴 환자의 치료를 위한 스테로이드 사용 현황과 효과성태정, 안요한, 유수지, 이건희, 이용주, 전지영, 조기영, 최성은대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2018 · 제6권 제2호

이 간행물의 다른 논문 (11건)

국내의 소아에서 분리된 폐구균의 항생제 감수성 양상 및 약력동학 모델을 이용한 적절한 항생제의 선택오지은, 백지연, 이환종, 조은영, 최은화, 최재홍, 이진아pp. 109-116국내 홍역, 유행성이하선염 및 풍진 백신 접종 후 연령에 따른 항체양성율 변화최경민, 방성준pp. 117-123우리나라의 B형 간염 조절 정책의 변화에 대한 조사고대균, 김종현, 한지윤, 정태웅pp. 124-134일개 대학병원 중환자실에 입원한 소아 환자에서 발생한 원내감염의 양상김수남, 조혜정, 은병욱, 손동우, 전인상, 차한, 심소연, 최덕영, 선용한, 조강호, 원종복pp. 135-142신생아황달 환아에서의 메티실린내성 황색포도알균 보균율에 관한 연구나동천, 이정현, 서재민, 김은령, 이원욱pp. 143-153
원문 보기